Stocks To Buy Forum

Stocks to Buy based on the Best Stock Market Research

Histogenics (HSGX) Stock Jumps on NeoCart Phase 1 and 2 Data

Histogenics (HSGX) stock is rallying 53% to $2.35 in pre market after the company released positive NeoCart Phase 1 and 2 data.  

Histogenics Announces Publication of MRI Data From NeoCart® Phase 1 and Phase 2 Clinical Trials in the American Journal of Sports Medicine

– Data demonstrate significant improvement in cartilage quality over first 24 months after treatment, with stabilization and maturation thereafter out to 60 months –

– Improvements in cartilage quality were accompanied by consistent and statistically significant improvements in patient reported clinical outcomes as early as 3 to 6 months after implantation –

– Data underscore potential to provide a faster and more durable recovery for patients with cartilage defects in the knee –

More Stocks to Watch -

Views: 134

Reply to This

Stocks to Buy 2018

Stocks to Buy 2018

Tesla (TSLA)
Small Cap Bull 3x (TNA)
Shake Shack (SHAK)
Stocks to Watch - 2018
Penny Stocks - 2018

Twitter - Free Stock Alerts

© 2018   Created by Stocks To Buy.   Powered by

Badges  |  Report an Issue  |  Terms of Service